Kellie Combs, Ropes & Gray life sciences partner, analyzes three documents released by the FDA outlining the agency’s current thinking regarding drug and device manufacturers’ communication of information not contained in FDA-approved labeling.
Trending Similar Videos
Changing values of IP and data in deals
Ed Black, co-head of Ropes & Gray’s IP transactions and technology, media & telecommunications practice groups, discusses changing values of IP and data in M&A transactions.
Pending Supreme Court PTAB cases
Scott McKeown, Ropes & Gray IP litigation partner and chair of the firm’s Patent Trial and Appeal Board (PTAB) group, discusses potential impacts of pending Supreme Court PTAB cases, Oil States and SAS Institute.
China’s new cybersecurity law
Mimi Yang, a Ropes & Gray government enforcement partner in Hong Kong, provides an overview of China’s new cybersecurity law (CSL), which came into effect in June 2017.
Cloud computing security
Jim DeGraw, Ropes & Gray technology partner, addresses cloud computing security issues that companies should be aware of as they consider moving data to the cloud.
Value-based health care: provider integration
John Chesley, Ropes & Gray health care partner, addresses developments for providers to consider as they integrate and move towards value-based health care models.
Value-based health care: the role of payors
Bill Knowlton, Ropes & Gray health care partner, examines the critically important role of payors in value-based health care programs.